A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment

PHASE3UnknownINTERVENTIONAL
Enrollment

670

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Chronic Lymphocytic Leukaemia
Interventions
DRUG

Ofatumumab

DRUG

Chlorambucil

DRUG

Bendamustine

Trial Locations (28)

Unknown

RECRUITING

Countess of Chester Hospital, Chester

RECRUITING

Derriford Hospital, Plymouth

RECRUITING

Torbay Hospital, Torquay

RECRUITING

Royal Bournemouth Hospital, Bournemouth

RECRUITING

Dorset County Hospital, Dorchester

RECRUITING

Colchester General Hospital, Colchester

RECRUITING

Basingstoke and North Hampshire Hospital, Basingstoke

RECRUITING

Southampton General Hospital, Southampton

RECRUITING

Barnet and Chase Farm Hospitals, Enfield

RECRUITING

Kent and Canterbury Hospital, Canterbury

RECRUITING

Maidstone Hospital, Maidstone

RECRUITING

Princess Royal Hospital, Orpington

RECRUITING

Queen Elizabeth Hospital, Woolwich

RECRUITING

West Middlesex University Hospital, Isleworth

RECRUITING

Ealing Hospital, Southall

RECRUITING

Hillingdon Hospital, Uxbridge

RECRUITING

Belfast City Hospital, Belfast

RECRUITING

Royal United Hospital, Bath

RECRUITING

Weston General Hospital, Weston-super-Mare

RECRUITING

Queens Hospital, Burton-on-Trent

RECRUITING

Queen Elizabeth Hospital, Gateshead

RECRUITING

Queen Elizabeth Hospital, Birmingham

RECRUITING

Bradford Royal Infirmary, Bradford

RECRUITING

Airdale General Hospital, Keighley

RECRUITING

St James University Hospital, Leeds

RECRUITING

Salisbury District Hospital, Salisbury

RECRUITING

Arrowe Park Hospital, Upton

RECRUITING

Royal Liverpool Hospital, Liverpool

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Napp Pharmaceuticals Limited

INDUSTRY

collaborator

Chugai Pharma USA

INDUSTRY

lead

University of Liverpool

OTHER